Drugs / AGN 201904
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00325715 | Apr → Aug 2006 | peptic ulcer disease | Allergan | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AGN 201904 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00325715 ↗ |
| Modality | Small molecule | “AGN 201904, a proton pump inhibitor” NCT00325715 ↗ |